Application N N Incl : Provide error if HHS does not E New Rule NIH, Type: Phase IIA support Phase October 2017 Phase IIA checked on the IIA Release (NIH) SBIR/STTR form FDA, and HHS is selected. VA N N Incl : Incl: SB1, Provide warning A previously W New Rule NIH, UB1 if applicant awarded Phase Readiness selects II, Direct Phase October 2017 Release (NIH) Program II, Fast Track or FDA, Readiness Phase IIB could Program but not be found. If previously your project was VA awarded Phase previously II, Direct Phase supported by a II, Fast Track or contract or Phase IIB could another agency, not be found contact the eRA Service Desk Phase I N N Incl : Incl: R41, Provide warning Phase I Letter of W New Rule NIH, Intent Number is Letter of R42, UT1, if Phase I Letter not required for October 2017 Intent UT2, R43, of Intent Number HHS agencies Release (NIH) number R44, U43, is provided FDA, and will be U44, SB1, ignored UB1
(NIH) Application Type: Phase IIA N N Incl : NIH, FDA, VA Provide error if Phase IIA checked on the SBIR/STTR form and HHS is selected. HHS does not support Phase IIA E New Rule October 2017 Release (NIH) Readiness Program N N Incl : NIH, FDA, VA Incl: SB1, UB1 Provide warning if applicant selects Readiness Program but previously awarded Phase II, Direct Phase II, Fast Track or Phase IIB could not be found A previously awarded Phase II, Direct Phase II, Fast Track or Phase IIB could not be found. If your project was previously supported by a contract or another agency, contact the eRA Service Desk W New Rule October 2017 Release (NIH) Phase I Letter of Intent number N N Incl : NIH, FDA, Incl: R41, R42, UT1, UT2, R43, R44, U43, U44, SB1, UB1 Provide warning if Phase I Letter of Intent Number is provided Phase I Letter of Intent Number is not required for HHS agencies and will be ignored W New Rule October 2017 Release
eSub-validations-draft-08-21-2017.docx